Sigyn Therapeutics Files 2024 10-K

Ticker: SIGY · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1642159

Sigyn Therapeutics, Inc. 10-K Filing Summary
FieldDetail
CompanySigyn Therapeutics, Inc. (SIGY)
Form Type10-K
Filed DateApr 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, healthcare

TL;DR

Sigyn Therapeutics filed its 2024 10-K on April 15, 2025. Check financials.

AI Summary

Sigyn Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on April 15, 2025. The company, previously known as Reign Resources Corp and Reign Sapphire Corp, is incorporated in Delaware and operates in the surgical and medical instruments sector. Its principal business address is in Beverly Hills, California.

Why It Matters

This filing provides a comprehensive overview of Sigyn Therapeutics' financial performance and business operations for the fiscal year 2024, offering insights into its current standing and future prospects.

Risk Assessment

Risk Level: low — This is a standard 10-K filing and does not contain immediate, specific risk-triggering information.

Key Numbers

  • 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
  • 2025-04-15 — Filing Date (Date the 10-K was submitted to the SEC)

Key Players & Entities

  • Sigyn Therapeutics, Inc. (company) — Filer
  • Reign Resources Corp (company) — Former company name
  • Reign Sapphire Corp (company) — Former company name
  • 2024-12-31 (date) — Fiscal year end
  • 2025-04-15 (date) — Filing date
  • Beverly Hills, California (location) — Business address

FAQ

What is the primary business of Sigyn Therapeutics, Inc.?

Sigyn Therapeutics, Inc. operates in the sector of SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].

When was Sigyn Therapeutics, Inc. previously known by other names?

The company was formerly known as Reign Resources Corp until May 12, 2020, and prior to that, as Reign Sapphire Corp until May 12, 2015.

What is the physical address of Sigyn Therapeutics, Inc.?

The company's business and mailing address is 9190 W OLYMPIC BLVD # 263, BEVERLY HILLS, CA 90212.

What is the SEC file number for Sigyn Therapeutics, Inc.?

The SEC file number for Sigyn Therapeutics, Inc. is 000-55575.

What period does this 10-K filing cover?

This 10-K filing covers the fiscal year ending December 31, 2024.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Sigyn Therapeutics, Inc. (SIGY).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.